Cellarcus Technologies seeks to participate in the Innovation Corps at NIH Program (i-Corps) to better understand the customers and markets for its extracellular vesicle (EV) analysis technology funded under Phase I SBIR R43 DA 044616.
Cellarcus Technologies is developing innovative new technologies for the measurements of extracellular vesicles (EVs). Cellarcus seeks to participate in the Innovation Corps at NIH Program (i-Corps) to better understand the customers and markets for its EV analysis technology.